mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000
Current Jobs

Hospital Representative
Location: Glasgow

Hospital Representative
Location: Kent and Sussex

Territory Manager - Charter Healthcare
Location: Scotland

Health Economy Liaison Manager
Location: East Midlands

Product Manager
Location: Berkshire

Health Economy Liaison Manager
Location: South West

Health Economy Liaison Manager
Location: South London

Health Economy Liaison Manager
Location: South Central

ITC Team Leader
Location: Herts

ITC Specialist
Location: Herts

Advanced Dispatch Coordinator
Location: Buckinghamshire

Medical Sales Person
Location: Gloucester and Cheltenham.

Veterinary Business Manager
Location: Taunton, Exeter, Plymouth

Key Account Manager - Reproductive Health
Location: Kent, Sussex, London

Key Account Manager - Growth Hormone
Location: Southampton, Oxford, Reading, Swindon, West London

Pfizer Animal Health's drug permitted to treat canine cancer

Posted on 04/06/2009 in Veterinary Supplier News

Pfizer Animal Health is proud to be able to launch the first canine cancer treatment approved by the Food and Drug Administration, it has asserted.

The regulatory body has permitted Palladiatm (toceranib phosphate) to be used to manage mast cell tumours in dogs.

Animal caregivers who want to find out what remedy to use for a pet with the disease should consult their vet, who may refer the newly-approved drug.

George Fennell, vice-president of Pfizer Animal Health's companion animal division, said the company will introduce the treatment to specialists over the coming weeks and months.

"The experience gained during this time will enable us to support veterinarians more effectively when we make the product available for purchase in early 2010," he explained.

Last month, Pfizer Animal Health was granted approval from the European Commission to market its swine vaccine Improvac across the EU.

Now permitted in 52 countries, it is designed to provide a reduction of boar taint in male pigs to improve the profitability and sustainability of production.

Other news stories from 04/06/2009

Read more in the Zenopa News Archive

How this news is generated

Mark Denton
Managing Director


home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use